CNTG Stock Summary and Trading Ideas (Centogene N.V. - Common Shares | NASDAQ:CNTG)

Centogene NV is a United States-based company focused on transforming clinical and genetic data into actionable information for patients, physicians, and pharmaceutical companies. The company operates in three segments: pharmaceutical, diagnostics, and COVID-19. Its pharmaceutical segment provides a variety of services to its pharmaceutical partners, including early patient recruitment and identification, epidemiological insights, biomarker discovery, and patient monitoring. Its clinical diagnostics segment provides targeted genetic sequencing and diagnostics services to patients.

Centogene N.V. - Common Shares trades on the NASDAQ stock market under the symbol CNTG.

As of April 19, 2024, CNTG stock price climbed to $0.47 with 4,851 million shares trading.

CNTG has a beta of 1.88, meaning it tends to be more sensitive to market movements. CNTG has a correlation of 0.05 to the broad based SPY ETF.

CNTG has a market cap of $10.62 million. This is considered a Sub-Micro Cap stock.

In the last 3 years, CNTG stock traded as high as $11.95 and as low as $.45.

CNTG has underperformed the market in the last year with a price return of -31.9% while the SPY ETF gained +21.8%. CNTG has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -62.4% and -33.8%, respectively, while the SPY returned +4.8% and -3.0%, respectively.

CNTG support price is $.41 and resistance is $.51 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CNTG stock will trade within this expected range on the day.